| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/13/2002 | EP1186654A1 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 narine aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
| 03/13/2002 | EP1186295A1 Pharmaceutical preparations containing extracts of soy isoflavone and probiotic micro-organisms |
| 03/13/2002 | EP1185662A2 Dna vaccines for pets and sport animals |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185639A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer |
| 03/13/2002 | EP1185628A2 Isolation of a human retrovirus |
| 03/13/2002 | EP1185626A2 A method for the transfer of antigens to dendritic cells |
| 03/13/2002 | EP1185625A2 Neuronal cell material, use of said material as a transplant and method for producing the same |
| 03/13/2002 | EP1185622A1 Methods of making pancreatic islet cells |
| 03/13/2002 | EP1185621A2 Surface for cell culture |
| 03/13/2002 | EP1185620A2 Spheroid preparation |
| 03/13/2002 | EP1185618A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 03/13/2002 | EP1185612A2 Bioreactor design and process for engineering tissue from cells |
| 03/13/2002 | EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185536A2 Hemisynthetic method and intermediates thereof |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185299A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | EP1185279A2 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 03/13/2002 | EP1185258A1 Therapeutic uses for nitric oxide inhibitors |
| 03/13/2002 | EP1023030A4 Method and bottle for infant feeding |
| 03/13/2002 | EP0986394B1 Anti-coagulation of blood, blood plasma or synovial fluid products |
| 03/13/2002 | EP0951290B1 Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal |
| 03/13/2002 | EP0869805B1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 03/13/2002 | EP0673652B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340098A Astrocytes, their preparation and use thereof |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339583A Recombined smegmatis mycobacterium, its preparation and use in medicine for treating bladder tumor |
| 03/13/2002 | CN1339313A Pure traditional Chinese medicine for relaxing muscles and tendons and promoting blood circulation |
| 03/13/2002 | CN1339306A Gastric ulcer ointment |
| 03/13/2002 | CN1339305A Chinese patent medicine for curing peptic ulcer |
| 03/13/2002 | CN1339301A New lactic acid fungus preparation having biological purifying activity |
| 03/13/2002 | CN1339300A use of pearl powder in making medicine |
| 03/13/2002 | CN1080574C Yuchuang ointment for treating sore |
| 03/13/2002 | CN1080573C Health care medicine power for infant |
| 03/13/2002 | CN1080571C Chinese medicine for treating diseases caused by fatigue |
| 03/13/2002 | CN1080570C Psoriasis winie and its producing process |
| 03/13/2002 | CN1080569C Prescription of Yizhifutanwan for reinforcing wisdom and rehabilitating paralysis |
| 03/13/2002 | CN1080568C Myopia treating medicine |
| 03/13/2002 | CN1080567C Kidney-supplementing yang-invigorating channels-freeing dampness-dispelling medicinal liquor |
| 03/13/2002 | CN1080564C Medicine for treatment of aplastic anemia and its preparation method |
| 03/12/2002 | US6355859 Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease |
| 03/12/2002 | US6355774 Isolated p27 protein |
| 03/12/2002 | US6355622 Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell |
| 03/12/2002 | US6355479 Insect polypeptide for use in the treatment of autoimmune diseases, allergies and cancer |
| 03/12/2002 | US6355475 Generating fungal culture; obtain fungus, incculate and propagate fungus harvesting the culture |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355252 Antiinflammatory agents |
| 03/12/2002 | US6355242 Materials and methods for treating or preventing oxalate-related disease |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | US6355239 Uses for non-autologous mesenchymal stem cells |
| 03/12/2002 | US6355238 Specific immune system modulation |
| 03/12/2002 | CA2357081A1 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor |
| 03/12/2002 | CA2201729C Selective process for the deacylation of acylated compounds |
| 03/12/2002 | CA2023895C Hypoallergenic milk products and process of making |
| 03/11/2002 | CA2356466A1 Pharmaceutical preparations containing soy isoflavone extracts and probiotic micro-organisms |
| 03/08/2002 | CA2358061A1 Novel antibody compositions for the negative selection of specific rat leukocyte subsets |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018605A2 Anti-microbial agents |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018546A2 Plasma-derived-fibrin-based matrices and tissue |
| 03/07/2002 | WO2002018441A2 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002017983A1 Medicinal compositions for forming tissue around bone or tooth, process for preparing the same, injections for forming tissue around bone or tooth and process for preparing the same |
| 03/07/2002 | WO2002017980A2 Methods and compositions for tissue regeneration |
| 03/07/2002 | WO2002017944A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 03/07/2002 | WO2002017943A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 03/07/2002 | WO2002017942A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 03/07/2002 | WO2002017941A1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 03/07/2002 | WO2002017940A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 03/07/2002 | WO2002017936A1 Methods for processing animal tissues |
| 03/07/2002 | WO2002017935A2 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease |
| 03/07/2002 | WO2002017934A1 Natural, non-allergenic, immune system stimulant |
| 03/07/2002 | WO2002017917A1 Manzamines for treatment of drug resistant infection |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001078757A3 Reversible immortalization |
| 03/07/2002 | WO2001078649A3 Pharmaceutical curative compound |
| 03/07/2002 | WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy |
| 03/07/2002 | WO2001068122A3 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 03/07/2002 | WO2001060983A3 Treatment for bone disorders |
| 03/07/2002 | WO2001060414A3 Genetic modification of the lung as a portal for gene delivery |
| 03/07/2002 | WO2001056599A3 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 03/07/2002 | WO2001051093A3 METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS |
| 03/07/2002 | WO2001043761A3 Methods for treating and preventing damage to mucosal tissue |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | US20020028785 Telomerase resistance; anticancer agents |
| 03/07/2002 | US20020028775 Using mixture of flavonoids, cytochrome inhibitor, sugar, phosphate in carrier |
| 03/07/2002 | US20020028765 Process for improving the growth of human head hair |
| 03/07/2002 | US20020028510 Cells for use in the treatment of nervous system disorders |
| 03/07/2002 | US20020028497 Method for producing recombinant adenovirus |